President Barack Obama announced a campaign designed to develop treatments for some of the least understood brain disorders, a push that could benefit Pfizer Inc., Roche Holding AG and Eli Lilly & Co.
The effort, called the BRAIN Initiative, will spend $100 million beginning in 2014 to map the complex interactions between brain cells and neurological circuits. The goal is to find treatments for some of the most common brain disorders, including Alzheimer’s, epilepsy and brain injuries, according to an administration statement today.
“Ideas are what power our economy,” Obama said today in the East Room of the White House. “We do innovation better than anybody else, and that makes our economy stronger.”
The first $100 million will be part of the fiscal 2014 budget coming out April 10, the president said.
To contact the editor responsible for this story: Reg Gale at firstname.lastname@example.org